BioSpace News Archive

Press Releases

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

October 29, 2024
·
2 min read
Press Releases

Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

October 29, 2024
·
6 min read
Press Releases

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

October 29, 2024
·
8 min read
Press Releases

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

October 29, 2024
·
4 min read
Press Releases

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

October 29, 2024
·
8 min read
Press Releases

Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia

October 29, 2024
·
10 min read
Press Releases

AuraVax Therapeutics awarded contract from BARDA to evaluate NanoSTING platform as mucosal adjuvant for intranasal pandemic influenza vaccine

October 29, 2024
·
4 min read
Press Releases

AbbVie’s VRAYLAR® (cariprazine) Now Publicly Reimbursed in Ontario

October 29, 2024
·
3 min read
Press Releases

Rallybio Announces Approval of Clinical Trial Applications for Phase 2 Trial of RLYB212 in Pregnant Women at Higher Risk of Alloimmunization and FNAIT

October 29, 2024
·
6 min read
Press Releases

First Subject Enrolled in Tivic Health’s Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

October 29, 2024
·
4 min read